tetano
Editor, Senior Moderator
Front Immunol. 2020 Apr 24;11:879. doi: 10.3389/fimmu.2020.00879. eCollection 2020.
Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.
Lee CY[SUP]1[/SUP], Lin RTP[SUP]2,[/SUP][SUP]3[/SUP], Renia L[SUP]1,[/SUP][SUP]3[/SUP], Ng LFP[SUP]1,[/SUP][SUP]4,[/SUP][SUP]5[/SUP].
Author information
Abstract
Since December 2019, the novel coronavirus, SARS-CoV-2, has garnered global attention due to its rapid transmission, which has infected more than two million people worldwide. Early detection of SARS-CoV-2 is one of the crucial interventions to control virus spread and dissemination. Molecular assays have been the gold standard to directly detect for the presence of viral genetic material in infected individuals. However, insufficient viral RNA at the point of detection may lead to false negative results. As such, it is important to also employ immune-based assays to determine one's exposure to SARS-CoV-2, as well as to assist in the surveillance of individuals with prior exposure to SARS-CoV-2. Within a span of 4 months, extensive studies have been done to develop serological systems to characterize the antibody profiles, as well as to identify and generate potentially neutralizing antibodies during SARS-CoV-2 infection. The vast diversity of novel findings has added value to coronavirus research, and a strategic consolidation is crucial to encompass the latest advances and developments. This review aims to provide a concise yet extensive collation of current immunoassays for SARS-CoV-2, while discussing the strengths, limitations and applications of antibody detection in SARS-CoV-2 research and control.
Copyright ? 2020 Lee, Lin, Renia and Ng.
KEYWORDS:
COVID-19; SARS-CoV-2; antibodies; detection; immunoassays; nucleocapsid; receptor binding domain; spike
PMID:32391022PMCID:PMC7194125DOI:10.3389/fimmu.2020.00879
Free full text
Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.
Lee CY[SUP]1[/SUP], Lin RTP[SUP]2,[/SUP][SUP]3[/SUP], Renia L[SUP]1,[/SUP][SUP]3[/SUP], Ng LFP[SUP]1,[/SUP][SUP]4,[/SUP][SUP]5[/SUP].
Author information
Abstract
Since December 2019, the novel coronavirus, SARS-CoV-2, has garnered global attention due to its rapid transmission, which has infected more than two million people worldwide. Early detection of SARS-CoV-2 is one of the crucial interventions to control virus spread and dissemination. Molecular assays have been the gold standard to directly detect for the presence of viral genetic material in infected individuals. However, insufficient viral RNA at the point of detection may lead to false negative results. As such, it is important to also employ immune-based assays to determine one's exposure to SARS-CoV-2, as well as to assist in the surveillance of individuals with prior exposure to SARS-CoV-2. Within a span of 4 months, extensive studies have been done to develop serological systems to characterize the antibody profiles, as well as to identify and generate potentially neutralizing antibodies during SARS-CoV-2 infection. The vast diversity of novel findings has added value to coronavirus research, and a strategic consolidation is crucial to encompass the latest advances and developments. This review aims to provide a concise yet extensive collation of current immunoassays for SARS-CoV-2, while discussing the strengths, limitations and applications of antibody detection in SARS-CoV-2 research and control.
Copyright ? 2020 Lee, Lin, Renia and Ng.
KEYWORDS:
COVID-19; SARS-CoV-2; antibodies; detection; immunoassays; nucleocapsid; receptor binding domain; spike
PMID:32391022PMCID:PMC7194125DOI:10.3389/fimmu.2020.00879
Free full text